Key Takeaways
- Flat revenue, margin reset year: Total income was flattish at ₹558 crores YoY while EBITDA margin softened 222 bps to 23.85%, as the company deployed CAPEX into a new plant, corporate office and brand building, and absorbed a transitional FMCG quarter.
- FMCG softness is the main drag: The cleaning and hygiene segment dropped almost 18% on a mix shift to lower-category products when detergent raw material prices rose; management calls it temporary and expects normalization within a month or two.
- New engines are firing early: Water treatment and oil & gas delivered strong volume and value growth, backed by a robust order pipeline and inquiries from global majors, while the newly approved AquaStrike Premium mosquito control solution opened institutional and export channels.
- Deferred orders mask underlying textile strength: Textile volumes rose 15% and revenue ~10%, but certain deliveries were postponed by geopolitical disruptions in Bangladesh and trade-related friction; those orders are expected to be fulfilled this financial year.
- What to watch next quarter: Whether the promised FMCG normalization actually materializes, the pace of order conversion in oil & gas, and any concrete update on the ongoing acquisition negotiations.
FMCG Segment: The Quarter’s Weak Link
- Volume-led drop: The segment supplying detergent and FMCG companies fell almost 18%, driven by a customer shift to lower-category products when crude-linked raw material prices rose from November/December, reducing demand for Fineotex’s specialty performance boosters and sustainable solutions.
- Mix shift, not customer loss: Management confirmed no customer was lost; the weakness came from existing customers trading down their product mix, plus a transition from powders to liquid detergents that takes a quarter or two to absorb.
- Proactive response underway: The company expanded geographically, added new customers, developed more sustainable solutions, and is pitching to MNC clients, though management declined to share specifics on MNC progress.
- Recovery timeline: Management expects the detergent market to normalize because crude prices have softened, and stated that “by coming month or another month everything should be getting back to normalcy.”
Tibrewala: “we are producing the paneers and the cheese of the products, and when the markets are not good, people do not have the cheese than the paneer, they have more of the idlis than the dosas”
Textile: Stable Core with Deferred Upside
- Underlying demand intact: Textile volumes grew 15% and revenue nearly 10% YoY, with sustained demand across key geographies and 25 new customers added during the quarter.
- Deferred deliveries: Certain orders were postponed in Q4 due to geopolitical tensions in Bangladesh and trade-related disruptions; these are expected to be fulfilled in the current financial year, though management could not quantify the deferred value on the call.
- Optimistic outlook: Management described textiles as “already booming for Fineotex” and called the sector “one of the most optimistic” from June onward, citing a hoped-for revival in Indian textile markets.
New Growth Engines: Oil & Gas, Water Treatment, AquaStrike
- Oil & gas gaining scale: The segment delivered strong volume and value growth, with management stating it will become “one of the very important segments going forward.” The company has signed NDAs with giant global oil and gas firms, exhibited at NFT Russia, and has teams deployed in the Middle East and Russia.
- Supply-chain displacement opportunity: One global major has been mandated by its US headquarters to divert $500 million of chemical procurement from China to India; management said “we are drenched with inquiries” and noted the Russian market alone needs ₹70,000 crores of oil and gas chemicals.
- Fungible capacity: Existing manufacturing capacity is fungible across polymerization, esterification, sulfonation and phosphonation, and the company has been a vendor to ONGC since 2008, so no dedicated new capacity is required to serve oil and gas.
- Water treatment: Delivered strong performance with substantial volume and value increases, backed by a robust and growing order pipeline.
- AquaStrike Premium launched: A next-generation biotechnology-based mosquito control solution using Azadirachtin, non-toxic and eco-friendly, received Central Insecticide Board approval and Hopkins Institute validation showing 100% mortality in two to three hours. Already sold in Singapore and Vietnam, with reports submitted to several Indian state governments.
Tibrewala: “we have got great results and we are seeing a mortality rate of 100% in the use of two to three hours, which is quite phenomenal actually”
Margins & Investment Phase
- EBITDA margin walk: Margin softened 222 bps to 23.85%, driven by CAPEX deployment (new greenfield plant, new Andheri corporate office), brand-building initiatives for new product segments, and investments in sales promotion and team additions.
- PAT pressure: PAT fell to ₹109 crores from ₹121 crores YoY, and to approximately ₹20 crores in Q4 from ₹27 crores in the prior quarter, reflecting the margin compression plus higher depreciation and an inventory loss.
- Return ratios moderated: ROCE at 23.56% and ROE at 18.32% were “moderately and temporarily impacted” by the higher capital base from the fund raise, though management cited prudent working capital management.
- Confidence in recovery: Management expressed confidence in delivering “similar kind of performances as we have done in the last four or five years in the EBITDA percentages,” citing the new initiatives and brand-building now in place.
Tibrewala: “we are quite confident that we will be having similar kind of performances as we have done in the last four or five years in the EBITDA percentages.”
Capacity, Product Engine & Inorganic Options
- Greenfield plant on track: The new facility aims to commence operations by Q2 FY26, adding 15,000 MTPA to take total installed capacity to 1,20,000 MTPA.
- R&D output: 30 new products were developed during the year, including 15 in Q4 alone, spanning the core textile and FMCG segments as well as the new verticals.
- Inorganic pipeline: Management confirmed acquisition negotiations are ongoing, with “a lot of changes” in the last four to five months, but stated any material fact will be shared via stock exchange. No timeline was given.
- Warrant conversion: Promoters have invested ~₹11 crores with ~₹33 crores yet to be converted by November; management noted that even if 75% is not converted, 25% is retained by the company tax-free and added to reserves, and the company has enough cash for organic or inorganic opportunities.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Greenfield plant operational | Add 15,000 MTPA capacity | Q2 FY26 |
| Deferred order fulfillment | Orders postponed in Q4 FY25 due to geopolitical disruptions | Current financial year (FY26) |
| FMCG segment normalization | Detergent market to normalize as crude prices have softened | “By coming month or another month” |
| Textile revival | Indian textile markets revival expected | “From June onward” |
| EBITDA margin recovery | Confident of similar performance as last 4–5 years | No date; implied ongoing |
| Warrant conversion balance | Promoter ~₹33 crores yet to convert | By November |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Total income (FY25) | ₹558 cr, flattish YoY |
| Gross profit (FY25) | ₹205 cr, gross margin stable at 38.57% |
| EBITDA (FY25) | ₹127 cr, EBITDA margin softened 222 bps to 23.85% |
| PAT (FY25) | ₹109 cr, vs ₹121 cr in FY24; PAT margin at 20.48% |
| PAT (Q4) | ~₹20 cr, down from ~₹27 cr in Q3 |
| Operating cash flow (FY25) | ₹69.33 cr, CFO to EBITDA ratio of 54.50% |
| Cash and equivalents | ₹352 cr at year-end, after capex deployment |
| ROCE (FY25) | 23.56% |
| ROE (FY25) | 18.32% |
| Revenue mix, textiles (FY25) | 73% of total income |
| Export share | 22% of total income during the quarter |
| Textile volume growth (FY25) | +15% YoY |
| FMCG segment volume decline (Q4) | ~18% drop in supplies to detergent and FMCG companies |
| Overall volume change (FY25) | ~10% decline YoY |
| Capacity utilization (FY25) | ~59–60% |
| New customers added (Q4) | 25 |
| New products developed (Q4) | 30 |
| Greenfield expansion, additional capacity | 15,000 MTPA, taking total installed capacity to 1,20,000 MTPA, operations expected Q2 FY26 |